The health impact of undiagnosed airflow obstruction in a national sample of United States adults

被引:174
作者
Coultas, DB
Mapel, D
Gagnon, R
Lydick, E
机构
[1] Univ Florida, Hlth Sci Ctr, Jacksonville, FL 32246 USA
[2] Lovelace Sci Resources, Albuquerque, NM USA
[3] SmithKline Beecham Pharmaceut, Collegeville, PA USA
关键词
airflow obstruction; spirometry; health impact; screening;
D O I
10.1164/ajrccm.164.3.2004029
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
To determine the health and functional impact of undiagnosed airflow obstruction for subjects in the general population, we used data obtained as part of the Third National Health and Nutrition Examination Survey (NHANES III). Categories of diagnosed and undiagnosed airflow obstruction were defined using questionnaire responses and spirometric results. Health and functional impact of airflow obstruction was assessed from responses to questions about general health status, walking 1/4 mile, lifting or carrying something as heavy as 10 lb, or needing help with personal care. Undiagnosed airflow obstruction (12.0%) was more common than doctor-diagnosed chronic obstructive pulmonary disease (COPD) (3.1%) or asthma (2.7%). Although undiagnosed airflow obstruction was usually very mild, approximately 5% of the entire sample had an FEV, less than 75% predicted. After adjusting for smoking, obesity, and comorbid conditions, the risk of impaired health and functional status with undiagnosed airflow obstruction was independently associated with severity of FEV, impairment. For males and females, ever smoking was strongly associated with all types of airflow obstruction, diagnosed or not. However, among females with airflow obstruction, 12.2% to 35.2% never smoked. Undiagnosed airflow obstruction is common in the general population of the United States and is associated with impaired health and functional status.
引用
收藏
页码:372 / 377
页数:6
相关论文
共 32 条
[1]
LUNG-FUNCTION TESTING - SELECTION OF REFERENCE VALUES AND INTERPRETATIVE STRATEGIES [J].
不详 .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (05) :1202-1218
[2]
[Anonymous], 1987, Am Rev Respir Dis, V136, P1285
[3]
[Anonymous], [No title captured]
[4]
EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[5]
THE EFFECT OF PULMONARY IMPAIRMENT ON ALL-CAUSE MORTALITY IN A NATIONAL COHORT [J].
BANG, KM ;
GERGEN, PJ ;
KRAMER, R ;
COHEN, B .
CHEST, 1993, 103 (02) :536-540
[6]
Glucocorticoid therapy for chronic obstructive pulmonary disease [J].
Boushey, HA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) :1990-1991
[7]
LONGITUDINAL CHANGES IN FORCED EXPIRATORY VOLUME IN ONE 2ND IN ADULTS - EFFECTS OF SMOKING AND SMOKING CESSATION [J].
CAMILLI, AE ;
BURROWS, B ;
KNUDSON, RJ ;
LYLE, SK ;
LEBOWITZ, MD .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 135 (04) :794-799
[8]
CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77
[9]
Screening older patients for obstructive airways disease [J].
Crockett, A .
THORAX, 1999, 54 (06) :472-473
[10]
Screening older patients for obstructive airways disease in a semi-rural practice [J].
Dickinson, JA ;
Meaker, M ;
Searle, M ;
Ratcliffe, G .
THORAX, 1999, 54 (06) :501-505